+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

CRISPR-based Gene Editing Market Size, Share & Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), by Application (Biomedical, Agricultural), by End Use, by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 6009890
The global CRISPR-based gene editing market size was estimated at USD 4.01 billion in 2024 and is projected to reach USD 13.50 billion by 2033, growing at a CAGR of 14.7% from 2025 to 2033. This growth is driven by the rising prevalence of genetic disorders, advancements in research and technology, supportive government initiatives, and increasing investment in biotechnology.

Advancements in CRISPR Technology & Applications

Advancements in CRISPR technology and applications are significantly accelerating market growth by enhancing precision, efficiency, and versatility in gene editing. Since its discovery, the CRISPR-Cas system has evolved beyond basic DNA cutting into a sophisticated genome engineering platform. It is supported by innovations such as high-fidelity Cas variants, base editing, prime editing, and improved delivery mechanisms such as lipid nanoparticles and viral vectors. These improvements have reduced off-target effects, increased editing efficiency, and broadened the scope of treatable conditions. Integration with artificial intelligence (AI) and machine learning has further optimized guide RNA design and target site selection, enabling faster, more accurate development cycles. Technology’s adaptability also supports multiplexed editing, allowing simultaneous modification of multiple genes crucial for tackling complex diseases and traits.

These advancements also expand CRISPR into new application areas beyond human therapeutics, including agriculture, industrial biotechnology, diagnostics, and environmental management. In agriculture, CRISPR is being applied to create climate-resilient, pest-resistant, and nutrient-enhanced crops, offering solutions to food security challenges. In diagnostics, CRISPR-based tools such as SHERLOCK and FELUDA enable rapid, low-cost detection of infectious diseases. At the same time, in synthetic biology, CRISPR is used to engineer microorganisms for sustainable biofuel and material production. The widening scope of CRISPR applications, coupled with ongoing technical refinements, is attracting strong investments from pharmaceutical companies, agri-biotech firms, and research institutions. This continual innovation cycle expands the addressable market and strengthens CRISPR’s position as a transformative technology platform across multiple industries.

Global CRISPR-based Gene Editing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the global CRISPR-based gene editing market based on product & service, application, end use, and region:

Product & Service Outlook (Revenue, USD Million, 2021-2033)

  • Products
  • CRISPR Kits & Reagents
  • CRISPR Libraries
  • Others
  • Services

Application Outlook (Revenue, USD Million, 2021-2033)

  • Biomedical
  • Therapeutic Development
  • By Indication
  • Genetic Disorders
  • Oncology
  • Ophthalmology
  • Others
  • By Delivery Method
  • Ex Vivo
  • In Vivo
  • Disease Diagnostics
  • Agricultural applications
  • Plant Engineering
  • Farm Animals Engineering
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Application Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. CRISPR-based Gene Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of genetic disorders
3.2.1.2. Growing investments in biotechnology and healthcare research
3.2.1.3. Advancements in CRISPR technology and applications
3.2.2. Market restraint analysis
3.2.2.1. Ethical concerns surrounding gene editing
3.2.2.2. High costs associated with CRISPR research and development
3.3. CRISPR-based Gene Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. CRISPR-based Gene Editing Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global CRISPR-based Gene Editing Market Product & Service Movement Analysis
4.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
4.4.2. CRISPR Kits & Reagents
4.4.2.1. CRISPR kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.4.3. CRISPR Libraries
4.4.3.1. CRISPR libraries market estimates and forecasts 2021 to 2033 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. CRISPR-based Gene Editing Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global CRISPR-based Gene Editing Market Application Movement Analysis
5.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Biomedical
5.4.1. Biomedical market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2. Therapeutic Development
5.4.2.1. Therapeutic development market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2. by Indication
5.4.2.2.1. Genetic Disorders
5.4.2.2.1.1. Genetic Disorders market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.2. Oncology
5.4.2.2.2.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.3. Ophthalmology
5.4.2.2.3.1. Ophthalmology market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.2.4. Others
5.4.2.2.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.4.2.3. by Delivery Method
5.4.2.3.1. Ex Vivo
5.4.2.3.1.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million
5.4.2.3.2. in Vivo
5.4.2.3.2.1. in vivo market estimates and forecasts 2021 to 2033 (USD Million
5.4.3. Disease Diagnostics
5.4.3.1. Disease diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Agricultural applications
5.5.1. Agricultural applications market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. Plant Engineering
5.5.2.1. Plant engineering market estimates and forecasts 2021 to 2033 (USD Million)
5.5.3. Farm Animals Engineering
5.5.3.1. Farm animals engineering market estimates and forecasts 2021 to 2033 (USD Million)
5.5.4. Others
5.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. CRISPR-based Gene Editing Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global CRISPR-based Gene Editing Market End Use Movement Analysis
6.3. Global CRISPR-based Gene Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Contract Research Organizations
6.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. CRISPR-based Gene Editing Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key country dynamics
7.4.2.2. Competitive scenario
7.4.2.3. Target disease prevalence
7.4.2.4. Regulatory framework
7.4.2.5. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key country dynamics
7.4.3.2. Competitive scenario
7.4.3.3. Target disease prevalence
7.4.3.4. Regulatory framework
7.4.3.5. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key country dynamics
7.4.4.2. Competitive scenario
7.4.4.3. Target disease prevalence
7.4.4.4. Regulatory framework
7.4.4.5. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Europe
7.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. UK
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Target disease prevalence
7.5.2.4. Regulatory framework
7.5.2.5. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Target disease prevalence
7.5.3.4. Regulatory framework
7.5.3.5. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4. France
7.5.4.1. Key country dynamics
7.5.4.2. Competitive scenario
7.5.4.3. Target disease prevalence
7.5.4.4. Regulatory framework
7.5.4.5. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key country dynamics
7.5.5.2. Competitive scenario
7.5.5.3. Target disease prevalence
7.5.5.4. Regulatory framework
7.5.5.5. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key country dynamics
7.5.6.2. Competitive scenario
7.5.6.3. Target disease prevalence
7.5.6.4. Regulatory framework
7.5.6.5. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key country dynamics
7.5.7.2. Competitive scenario
7.5.7.3. Target disease prevalence
7.5.7.4. Regulatory framework
7.5.7.5. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key country dynamics
7.5.8.2. Competitive scenario
7.5.8.3. Target disease prevalence
7.5.8.4. Regulatory framework
7.5.8.5. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key country dynamics
7.5.9.2. Competitive scenario
7.5.9.3. Target disease prevalence
7.5.9.4. Regulatory framework
7.5.9.5. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Asia-Pacific market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Target disease prevalence
7.6.2.4. Regulatory framework
7.6.2.5. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3. China
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Target disease prevalence
7.6.3.4. Regulatory framework
7.6.3.5. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4. India
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Target disease prevalence
7.6.4.4. Regulatory framework
7.6.4.5. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Target disease prevalence
7.6.5.4. Regulatory framework
7.6.5.5. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Target disease prevalence
7.6.6.4. Regulatory framework
7.6.6.5. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Target disease prevalence
7.6.7.4. Regulatory framework
7.6.7.5. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Target disease prevalence
7.7.2.4. Regulatory framework
7.7.2.5. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Target disease prevalence
7.7.3.4. Regulatory framework
7.7.3.5. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.8. MEA
7.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Target disease prevalence
7.8.2.4. Regulatory framework
7.8.2.5. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Target disease prevalence
7.8.3.4. Regulatory framework
7.8.3.5. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key country dynamics
7.8.4.2. Competitive scenario
7.8.4.3. Target disease prevalence
7.8.4.4. Regulatory framework
7.8.4.5. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key country dynamics
7.8.5.2. Competitive scenario
7.8.5.3. Target disease prevalence
7.8.5.4. Regulatory framework
7.8.5.5. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Revvity, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product/Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Danaher Corporation
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product/Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. GenScript
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product/Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Merck KGaA
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product/Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Thermo Fisher Scientific, Inc.
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product/Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Tocris Bioscience
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product/Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. OriGene Technologies, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product/Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Bio-Rad Laboratories
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product/Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Bio-Techne
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product/Service benchmarking
8.4.9.4. Strategic initiatives
8.4.10. New England Biolabs, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product/Service benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global CRISPR-based gene editing market, by region, 2021-2033 (USD Million)
Table 3 Global CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 4 Global CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 5 Global CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 6 North America CRISPR-based gene editing market, by country, 2021-2033 (USD Million)
Table 7 North America CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 8 North America CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 9 North America CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 10 U.S. CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 11 U.S. CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 12 U.S. CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 13 Canada CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 14 Canada CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 15 Canada CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 16 Mexico CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 17 Mexico CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 18 Mexico CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 19 Europe CRISPR-based gene editing market, by country, 2021-2033 (USD Million)
Table 20 Europe CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 21 Europe CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 22 Europe CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 23 UK CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 24 UK CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 25 UK CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 26 Germany CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 27 Germany CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 28 Germany CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 29 France CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 30 France CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 31 France CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 32 Italy CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 33 Italy CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 34 Italy CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 35 Spain CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 36 Spain CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 37 Spain CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 38 Denmark CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 39 Denmark CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 40 Denmark CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 41 Sweden CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 42 Sweden CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 43 Sweden CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 44 Norway CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 45 Norway CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 46 Norway CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 47 Asia-Pacific CRISPR-based gene editing market, by country, 2021-2033 (USD Million)
Table 48 Asia-Pacific CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 49 Asia-Pacific CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 50 Asia-Pacific CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 51 Japan CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 52 Japan CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 53 Japan CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 54 China CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 55 China CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 56 China CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 57 India CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 58 India CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 59 India CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 60 Australia CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 61 Australia CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 62 Australia CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 63 South Korea CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 64 South Korea CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 65 South Korea CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 66 Thailand CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 67 Thailand CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 68 Thailand CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 69 Latin America CRISPR-based gene editing market, by country, 2021-2033 (USD Million)
Table 70 Latin America CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 71 Latin America CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 72 Latin America CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 73 Brazil CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 74 Brazil CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 75 Brazil CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 76 Argentina CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 77 Argentina CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 78 Argentina CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 79 MEA CRISPR-based gene editing market, by country, 2021-2033 (USD Million)
Table 80 MEA CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 81 MEA CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 82 MEA CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 83 South Africa CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 84 South Africa CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 85 South Africa CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 86 Saudi Arabia CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 87 Saudi Arabia CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 88 Saudi Arabia CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 89 UAE CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 90 UAE CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 91 UAE CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
Table 92 Kuwait CRISPR-based gene editing market, by product & service, 2021-2033 (USD Million)
Table 93 Kuwait CRISPR-based gene editing market, by application, 2021-2033 (USD Million)
Table 94 Kuwait CRISPR-based gene editing market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 CRISPR-based gene editing market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Competitive landscape snapshot
Figure 15 Market trends & outlook
Figure 16 Porter’s five force analysis
Figure 17 PESTEL analysis
Figure 18 CRISPR-based Gene editing market: Product & service outlook key takeaways
Figure 19 CRISPR-based Gene editing market: Product & service movement analysis
Figure 20 Products market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 CRISPR kits & reagents market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 CRISPR libraries market estimates and forecasts, 2021-2033 (USD Million)
Figure 23 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Services market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 CRISPR-based gene editing market: Application outlook key takeaways
Figure 26 CRISPR-based gene editing market: Application movement analysis
Figure 27 Biomedical market estimates and forecasts, 2021-2033 (USD Million)
Figure 28 Therapeutic development market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Genetic disorders market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Oncology market estimates and forecasts, 2021-2033 (USD Million)
Figure 31 Ophthalmology market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Ex vivo market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 in vivo market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Disease diagnostics market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Agricultural applications market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Plant engineering market estimates and forecasts, 2021-2033 (USD Million)
Figure 38 Farm animals engineering market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Others market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 CRISPR-based gene editing market: End Use outlook key takeaways
Figure 41 CRISPR-based gene editing market: End Use movement analysis
Figure 42 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Academic & research Institutes market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Contract research organizations market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Regional marketplace outlook, 2023 & 2033 (USD million)
Figure 46 Regional marketplace: Key takeaways
Figure 47 North America CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Key country dynamics
Figure 49 U.S. CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Key country dynamics
Figure 51 Canada CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Key country dynamics
Figure 53 Mexico CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Europe CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 UK CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Germany CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 France CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 Spain CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Italy CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Key country dynamics
Figure 66 Denmark CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Key country dynamics
Figure 68 Sweden CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Key country dynamics
Figure 70 Norway CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Asia-Pacific CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Japan CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 China CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 India CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Key country dynamics
Figure 79 Australia CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Key country dynamics
Figure 81 South Korea CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 Key country dynamics
Figure 83 Thailand CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 Brazil CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Argentina CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 88 Key country dynamics
Figure 89 South Africa CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 90 Key country dynamics
Figure 91 Saudi Arabia CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 Key country dynamics
Figure 93 UAE CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 94 Key country dynamics
Figure 95 Kuwait CRISPR-based gene editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 96 Market participant categorization
Figure 97 Company market position analysis, 2024
Figure 98 Strategic framework

Companies Mentioned

The major companies profiled in this CRISPR-based Gene Editing market report include:
  • Revvity, Inc.
  • Danaher
  • GenScript
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Tocris Bioscience
  • OriGene Technologies, Inc.
  • Bio-Rad Laboratories
  • Bio-Techne
  • New England Biolabs, Inc.

Table Information